The GLP-1 receptor-mediated activation of the AMPK pathway by GLP-1 has been shown to attenuate diabetes-induced endothelial dysfunction and diabetic nephropathy [50,51,52]. The gene discussed is GLP1R; the disease is diabetes mellitus.